A Randomized, Double-Blind, Parallel-Group Trial Comparing Casodex 150mg Once Daily With Placebo in Patients With Non-Metastatic Prostate Cancer.
A Randomized, Double-Blind, Parallel-Group Trial Comparing Casodex 150mg Once Daily With Placebo in Patients With Non-Metastatic Prostate Cancer.
The purpose of this trial is to study the effect of adjuvant or immediate hormonal therapy, versus placebo, in subjects who have either undergone a primary therapy (principally radical prostatectomy or radiotherapy) or who were otherwise to be managed by watchful waiting.
Inclusion Criteria:
Exclusion Criteria:
Holbuk, Denmark
NYK BING Falster, Denmark
Orhus, Denmark
S Nderborg, Denmark
OYS (oulu), Finland
BODU, Norway
Strummen, Norway
Tromsu, Norway
Govle, Sweden
Junkoping, Sweden
Malmu, Sweden
Urebro, Sweden
Ustersund, Sweden
VoSTEROS, Sweden
Vostervik, Sweden